Profesör
İstinye Üniversitesi
Tıp Fakültesi
İç Hastalıkları Anabilim Dalı
Yayın Bul
Kayıt bulundu: 1.138
0 aktif filtre
T-cell-redirecting therapies in early relapsed multiple myeloma: a systematic review and network meta-analysis
Merz M.
Journal of Hematology and Oncology, 2026
Correction: CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma (Molecular Cancer, (2021), 20, 1, (84), 10.1186/s12943-021-01380-0)
Gu C.
Molecular Cancer, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma
Kumar S.
Blood Cancer Journal, 2026
The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022
Comerford C.
British Journal of Haematology, 2026
The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022
Comerford, C
BRITISH JOURNAL OF HAEMATOLOGY, 2026
The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)
Ludwig H.
American Journal of Hematology, 2026
Response to the comment on “[11C]-Methionine PET/CT in evaluation of bone marrow infiltration and usage as a prognostic tool in multiple myeloma”
Ozkan E.
Annals of Nuclear Medicine, 2026
The Changing Landscape of Maintenance Therapy in Newly Diagnosed Multiple Myeloma: A Systematic Review With Network Meta-Analysis of the European Myeloma Network (EMN)
Ludwig, H
AMERICAN JOURNAL OF HEMATOLOGY, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis
Kastritis E.
Blood, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS
Zweegman S.
Blood Advances, 2026
Talquetamab-Daratumumab in Relapsed or Refractory Myeloma
Mina R.
New England Journal of Medicine, 2026
Non-cryopreserved hematopoietic stem cell transplantation compared to conventional autologous peripheral stem cell transplantation with cryopreserved stem cells among patients newly diagnosed with myeloma
Vural E.
Transfusion and Apheresis Science, 2026
Sayfa 1 / 95
